rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1070.70   -26.90   -2.45%
Volume 173,541
Prev close 1,097.60
Day's H/L (Rs.) 1,119.85 - 1,060.00
52wk H/L (Rs.) 1,275.00 - 483.00
Mkt Cap (Rs. Cr) 31,243.03
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1070.65   -27.35   -2.49%
Volume 1,489,148
Prev close 1098.00
Day's H/L (Rs.) 1,119.05 - 1,060.00
52wk H/L (Rs.) 1,273.30 - 482.90
Turnover (Rs. Lacs) 16,314.81
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 2,450 market voices)   

140 Characters
  Cancel
Vadlamudi Kumar - 12 hour(s) ago Sell Aurobindo it will go 1070 very soon
#Aurobindo-Pharma-Ltd
Reply   |   Share
Yallamanda Punuri - 12 hours ago  Grt Sir, Thank u so much for helping me to book profits, how abt tomorrow's tgt sir
Reply   |  Share
Samarth Singh - 22 hour(s) ago [SKB] TOP 5 STOCKS TO BUY NOW....BEST STOCKS TO PICK…WITH 90% ACCURACY GET BUY/SELL ALERTS ON MOBILE – VISIT http://rediff.ly/41nx6 or CALL 7509069109
#Aurobindo-Pharma-Ltd
Reply   |   Share

Realtime news for Aurobindo Pharma Ltd. (See all 759 news)

05 March 2015, 09:34
Add IT, pharma names to portfolio; Mastek, Aurobindo Pharma top bets: Daljeet Singh Kohli, IndiaNivesh - 29 min(s) ago
Budget boost for healthcare sector pushes pharma shares up 5% - 4 day(s) ago
India Finance Ministry kicks the can on Aurobindo, Glenmark foreign investment - 21 Feb 2015
Aurobindo Pharma Q3 net profit down - 19 Feb 2015
Aurobindo up 3%; BoAML sees 38% upside, bets on US growth - 20 Feb 2015

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 - 19 Feb 2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 - 17 Feb 2015

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
27.12
EPS (Rs.)
40.21
Sales (Rs. Cr)
2,097.99
Face Value (Rs.)
1
Net Profit
Margin (%)
 
16.31
Last Bonus
1:1
Last Dividend(%)
200
Return on
Average Equity
 
29.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Cadila Healthcare Ltd.
1,533.20
Ipca Laboratories Ltd.
664.35
Show more companies
Cadila Healthcare Ltd.
1,533.20
Ipca Laboratories Ltd.
664.35
Torrent Pharmaceuticals Ltd.
1,061.65
Biocon Ltd.
438.55
Lupin Ltd.
1,797.80
Apollo Hospitals Enterprise Ltd.
1,350.25
Ranbaxy Laboratories Ltd.
722.75
Ajanta Pharma Ltd.
2,926.60
Alembic Pharmaceuticals Ltd.
409.30
GlaxoSmithKline Pharmaceuticals Ltd.
3,078.30
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close